Deutsche Bank Ag\ I Bio, Inc. Transaction History

Deutsche Bank Ag\

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.23 - $0.46 $26,983 - $53,967	-117,320 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.3 - $0.61 $4,179 - $8,498	-13,932 Reduced 10.61%	117,320 $50,000
Q4 2021 Feb 11, 2022	BUY	$0.55 - $1.04 $3,821 - $7,226	6,949 Added 5.59%	131,252 $72,000
Q3 2021 Nov 04, 2021	SELL	$1.06 - $1.52 $2,078 - $2,980	-1,961 Reduced 1.55%	124,303 $132,000
Q2 2021 Aug 11, 2021	SELL	$1.22 - $1.65 $9,045 - $12,233	-7,414 Reduced 5.55%	126,264 $191,000
Q1 2021 May 13, 2021	BUY	$1.18 - $2.62 $5,268 - $11,698	4,465 Added 3.46%	133,678 $205,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $102,327 - $218,299	97,455 Added 306.87%	129,213 $136,000
Q3 2020 Nov 12, 2020	BUY	$1.7 - $6.41 $11,556 - $43,575	6,798 Added 27.24%	31,758 $65,000
Q2 2020 Aug 13, 2020	BUY	$0.87 - $2.46 $21,715 - $61,401	24,960 New	24,960 $55,000
Q1 2019 May 15, 2019	SELL	$0.75 - $1.0 $20 - $27	-27 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.57 - $1.05 $14 - $27	26 Added 2600.0%	27 $0
Q2 2018 Aug 14, 2018	BUY	$0.83 - $2.1 $0 - $2	1 New	1 $0

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.